Diadema Partners LP Immunocore Holdings PLC Call Options Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
126Shares Held
44.2MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$205 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$178 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$142 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$77.8 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$67.5 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.28B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...